Related Experiment Video

Updated: May 20, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)

Published on: April 19, 2013

Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease

Xiangfeng Lu1, Laiyuan Wang, Shufeng Chen

  • 1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center of Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Nature Genetics
|July 4, 2012
PubMed

Insights

This study identified four new genetic loci associated with coronary artery disease (CAD) in the Chinese Han population. These findings enhance our understanding of CAD genetic susceptibility in diverse ancestries.

Area of Science:

  • Genetics
  • Cardiovascular Disease Research
  • Population Genomics

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality globally.
  • Genetic factors play a significant role in CAD susceptibility.
  • Understanding population-specific genetic architecture is crucial for targeted interventions.

Purpose of the Study:

  • To identify novel genetic loci associated with coronary artery disease (CAD) in the Chinese Han population.
  • To replicate previously identified CAD loci in a large Chinese cohort.
  • To elucidate genetic pathways contributing to CAD risk.

Main Methods:

  • Meta-analysis of two genome-wide association studies (GWAS) for CAD.
  • Replication studies in an independent cohort of Chinese Han ancestry.
  • Statistical analysis to identify genome-wide significant loci (P < 5 × 10(-8)).

Main Results:

  • Identification of four novel genetic loci for CAD: TTC32-WDR35, GUCY1A3, C6orf10-BTNL2, and ATP2B1.
  • Replication of four previously reported CAD loci (PHACTR1, TCF21, CDKN2A-CDKN2B, C12orf51).
  • All identified loci were significant in the Chinese Han population.

Conclusions:

  • The study successfully identified novel genetic risk factors for CAD in the Chinese Han population.
  • Findings highlight shared and population-specific genetic underpinnings of CAD.
  • These discoveries offer new insights into biological pathways involved in CAD pathogenesis.

More Related Videos

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...